Related Experiment Video

Updated: Mar 31, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.5K

CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation

Chiara Ianes1, Pengfei Xu, Natalie Werz

  • 1Department of General and Visceral Surgery, Surgery Centre, Ulm University Hospital, Albert‑Einstein‑Allee 23, 89081 Ulm, Germany.

Amino Acids
|October 15, 2015
PubMed

Insights

Casein kinase 1 delta (CK1δ) activity is modulated by interactions with Cyclin-dependent kinases (CDKs). This discovery offers new avenues for developing therapeutic strategies targeting neurological diseases and cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Casein kinase 1 (CK1) protein kinases are highly conserved and ubiquitously expressed, regulating vital cellular processes.
  • Dysregulation of CK1 activity is implicated in neurological diseases and cancer, making it a key drug development target.
  • Understanding CK1 regulation mechanisms is crucial for advancing therapeutic strategies.

Purpose of the Study:

  • To identify cellular kinases that modulate the activity of Casein kinase 1 delta (CK1δ).
  • To investigate the functional consequences of interactions between CK1δ and other kinase complexes.
  • To explore the therapeutic potential of modulating CK1δ activity in cancer.

Main Methods:

  • Site-specific phosphorylation analysis of CK1δ's C-terminal domain.
  • In vitro kinase assays to assess CK1δ activity.
  • Cell-based assays using pancreatic cancer cells treated with Dinaciclib.

Main Results:

  • Cyclin-dependent kinase 2/Cyclin E (CDK2/E) and Cyclin-dependent kinase 5/p35 (CDK5/p35) were identified as modulators of CK1δ activity.
  • Pre-incubation with CDK2/E or CDK5/p35 reduced in vitro CK1δ activity.
  • Inhibition of CDKs by Dinaciclib increased CK1δ activity in pancreatic cancer cells.

Conclusions:

  • CK1δ activity is regulated by its interplay with CDK2/E and CDK5/p35 complexes.
  • These findings provide novel insights into CK1δ regulation.
  • The study highlights potential CK1δ-targeting therapeutic strategies for cancer and neurological disorders.

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.5K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
137.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

3.0K